0001192482-19-000430.txt : 20191113
0001192482-19-000430.hdr.sgml : 20191113
20191113210335
ACCESSION NUMBER: 0001192482-19-000430
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191108
FILED AS OF DATE: 20191113
DATE AS OF CHANGE: 20191113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Quaker BioVentures II LP
CENTRAL INDEX KEY: 0001497725
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39130
FILM NUMBER: 191216010
BUSINESS ADDRESS:
STREET 1: QUAKER BIOVENTURES
STREET 2: 2929 ARCH STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: (215) 988-6800
MAIL ADDRESS:
STREET 1: QUAKER BIOVENTURES
STREET 2: 2929 ARCH STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Quaker BioVentures Capital II, L.P.
CENTRAL INDEX KEY: 0001583083
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39130
FILM NUMBER: 191216011
BUSINESS ADDRESS:
STREET 1: CIRA CENTER
STREET 2: 2929 ARCH STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: 215-988-6800
MAIL ADDRESS:
STREET 1: CIRA CENTER
STREET 2: 2929 ARCH STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TELA Bio, Inc.
CENTRAL INDEX KEY: 0001561921
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 455320061
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY, SUITE 24
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 484-320-2930
MAIL ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY, SUITE 24
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-11-08
0001561921
TELA Bio, Inc.
TELA
0001497725
Quaker BioVentures II LP
150 MONUMENT ROAD, SUITE 207
BALA CYNWYD
PA
19004
0
0
1
0
0001583083
Quaker BioVentures Capital II, L.P.
150 MONUMENT ROAD, SUITE 207
BALA CYNWYD
PA
19004
0
0
1
0
Common Stock
2019-11-08
4
P
0
153846
13.00
A
888664
D
Common Stock
2019-11-13
4
C
0
345489
A
1234153
D
Common Stock
2019-11-13
4
C
0
516947
A
1751100
D
Series A Preferred Stock
2019-11-13
4
C
0
8530145
0
D
Common Stock
345489
0
D
Series B Preferred Stock
2019-11-13
4
C
0
12763434
0
D
Common Stock
516947
0
D
Warrant (right to buy)
1.16
2019-11-13
4
C
0
446813
0
D
2017-01-18
2027-01-18
Series B Preferred Stock
446813
0
D
Warrant (right to buy)
28.65
2019-11-13
4
C
0
446813
0
D
2019-11-13
2027-01-18
Common Stock
18096
446813
D
Reflects 705,530 shares of common stock received by the reporting person as a payment-in-kind dividend on Series A Preferred Stock and Series B Preferred Stock exempt from reporting under Rule 16a-9(a).
Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.
Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.
Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.
Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.
Quaker BioVentures II, L.P. By: Quaker Bioventures Capital II, L.P., its general partner By Quaker BioVentures Capital II, LLC, its general partner By: /s/ Adele C. Oliva, Executive Manager
2019-11-13
Quaker Bioventures Capital II, L.P., its general partner By: Quaker BioVentures Capital II, LLC, its general partner By: /s/ Adele C. Oliva, Executive Manager
2019-11-13